What would be your approach to a patient with a PIK3CA mutation after progressing on multiple lines of chemotherapy, immunotherapy and PARPi for gBRCA mutated metastatic TNBC?   

Liquid biopsy also showed AR amplification.  



Answer from: Medical Oncologist at Academic Institution